Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 11:2023:3719502.
doi: 10.1155/2023/3719502. eCollection 2023.

Coexistent Relapsing Polychondritis and Clinically Amyopathic Dermatomyositis: A Rare Association of Autoimmune Disorders

Affiliations
Case Reports

Coexistent Relapsing Polychondritis and Clinically Amyopathic Dermatomyositis: A Rare Association of Autoimmune Disorders

Rafael A Ríos-Rivera et al. Case Rep Rheumatol. .

Abstract

Relapsing polychondritis (RPC) is an uncommon autoimmune systemic disease characterized by recurrent inflammation of the cartilage tissue. It can occur alone or in association with other autoimmune diseases, vasculitis, or hematologic disorders. However, the association of RPC with dermatomyositis is extremely rare. Herein, we present a case of a 38-year-old man who developed concurrent RPC and clinically amyopathic dermatomyositis (CADM) manifested by auricular chondritis, nasal chondritis, polyarthritis, gottron papules, fingertip papules, skin biopsy consistent with dermatomyositis, and positive antimelanoma differentiation-associated gene 5 (MDA5) antibodies. RPC features resolved with corticosteroids, but CADM manifestations were resistant to corticosteroids, cyclophosphamide, azathioprine, and hydroxychloroquine. Subsequent therapy with rituximab was effective to control CADM manifestations. This case highlights the importance of recognizing CADM as part of the autoimmune diseases linked with RPC and maintaining a high level of awareness to initiate effective therapy to avoid the long-term complications associated with these conditions.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
(a) Right and (b) left auricular involvement characterized by purplish redness and swelling of the pinna but sparing the lobules.
Figure 2
Figure 2
Erythematous, flat-topped, hyperkeratotic papules on the dorsal metacarpophalangeal joints bilaterally (gottron papules).
Figure 3
Figure 3
Biopsy of the posterior aspect of the right elbow showing perivascular lymphohistiocytic infiltration without lichenoid changes (hematoxylin and eosin stain, 100x).
Figure 4
Figure 4
Erythematous fingertip papules.
Figure 5
Figure 5
Resolution of (a) fingertip papules and (b) gottron papules after rituximab therapy.

Similar articles

References

    1. Trentham D. E., Le C. H. Relapsing polychondritis. Annals of Internal Medicine . 1998;129(2):114–122. doi: 10.7326/0003-4819-129-2-199807150-00011. - DOI - PubMed
    1. Kent P. D., Michet C. J., Luthra H. S. Relapsing polychondritis. Current Opinion in Rheumatology . 2004;16(1):56–61. doi: 10.1097/00002281-200401000-00011. - DOI - PubMed
    1. Hazra N., Dregan A., Charlton J., Gulliford M. C., D’Cruz D. P. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology . 2015;54(12):2181–2187. doi: 10.1093/rheumatology/kev240. - DOI - PubMed
    1. Horváth A., Páll N., Molnár K., et al. A nationwide study of the epidemiology of relapsing polychondritis. Clinical Epidemiology . 2016;8:211–230. doi: 10.2147/clep.s91439. - DOI - PMC - PubMed
    1. Borgia F., Giuffrida R., Guarneri F., Cannavò S. Relapsing polychondritis: an updated review. Biomedicines . 2018;6(3):p. 84. doi: 10.3390/biomedicines6030084. - DOI - PMC - PubMed

Publication types

LinkOut - more resources